Researchers presenting a preclinical study at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrated the efficacy and optimal dose for targeted photodynamic therapy (tPDT) to treat prostate cancer before and during surgery. Prostate-specific...
Read full post here:
https://skpsoft.com/business/targeted-molecular-imaging-and-near-infrared-activated-therapy-treats-prostate-tumors-that-are-left-behind-or-too-challenging-for-surgery-sciencedaily/
Sunday, June 18, 2017
Targeted molecular imaging and near-infrared activated therapy treats prostate tumors that are left behind or too challenging for surgery -- ScienceDaily
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment